CEP55 抗体
(Centrosomal Protein 55kDa (CEP55))
Plays a role in mitotic exit and cytokinesis. Not required for microtubule nucleation. Recruits PDCD6IP and TSG101 to midbody during cytokinesis (By similarity).
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CEP55 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CEP55 抗体 (AA 1-464) | 人 | 小鼠 Monoclonal |
|
|
|
| CEP55 抗体 (AA 151-250) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 1-464) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 1-260) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 1-464) | 人 | 小鼠 Polyclonal |
|
|
|
| CEP55 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (N-Term) | 人, 犬, 豚鼠, 马, 猴 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 360-409) | 人, 大鼠, 小鼠, 犬, 豚鼠, 马, Cow, 兔, Pig, 猴, Bat | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 | 大鼠 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 50-130) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (pSer425) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 38-64) (PE) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 69-118) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 38-64) (APC) | 人 | 兔 Polyclonal |
|
|
|
| CEP55 抗体 (AA 1-464) | 人 | 小鼠 Polyclonal |
|
|
|
| CEP55 抗体 (AA 1-464) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6A10
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-464
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
2 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 151-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-464
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-260
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-464
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB22365
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 38-64, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 50-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer425
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 38-64
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 69-118
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 38-64
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-464
Latest Publications for our CEP55 抗体
: "CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma." in: Oncology letters, Vol. 13, Issue 1, pp. 236-242, (2017) (PubMed).
: "Midbody assembly and its regulation during cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 6, pp. 1024-34, (2012) (PubMed).
: "Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 14, pp. 2702-11, (2012) (PubMed).
: "MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 22, pp. 4347-61, (2012) (PubMed).
: "Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity." in: Nature cell biology, Vol. 13, Issue 10, pp. 1214-23, (2011) (PubMed).
: "PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody." in: Nature cell biology, Vol. 12, Issue 4, pp. 362-71, (2010) (PubMed).
: "Characterization of centrosomal proteins Cep55 and pericentrin in intercellular bridges of mouse testes." in: Journal of cellular biochemistry, Vol. 109, Issue 6, pp. 1274-85, (2010) (PubMed).
: "Essential role of hIST1 in cytokinesis." in: Molecular biology of the cell, Vol. 20, Issue 5, pp. 1374-87, (2009) (PubMed).
: "Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity." in: Oncogene, Vol. 28, Issue 30, pp. 2723-37, (2009) (PubMed).
: "Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 30, pp. 10541-6, (2008) (PubMed).
: "Midbody assembly and its regulation during cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 6, pp. 1024-34, (2012) (PubMed).
: "Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 14, pp. 2702-11, (2012) (PubMed).
: "MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 22, pp. 4347-61, (2012) (PubMed).
: "Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity." in: Nature cell biology, Vol. 13, Issue 10, pp. 1214-23, (2011) (PubMed).
: "PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody." in: Nature cell biology, Vol. 12, Issue 4, pp. 362-71, (2010) (PubMed).
: "Characterization of centrosomal proteins Cep55 and pericentrin in intercellular bridges of mouse testes." in: Journal of cellular biochemistry, Vol. 109, Issue 6, pp. 1274-85, (2010) (PubMed).
: "Essential role of hIST1 in cytokinesis." in: Molecular biology of the cell, Vol. 20, Issue 5, pp. 1374-87, (2009) (PubMed).
: "Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity." in: Oncogene, Vol. 28, Issue 30, pp. 2723-37, (2009) (PubMed).
: "Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 30, pp. 10541-6, (2008) (PubMed).
Aliases for CEP55 抗体
centrosomal protein 55 (CEP55) 抗体centrosomal protein 55 (Cep55) 抗体
1200008O12Rik 抗体
2700032M20Rik 抗体
C10orf3 抗体
CT111 抗体
RGD1305340 抗体
URCC6 抗体
您还需要查找其他产品吗？
You are here:
